?
This is an uncorrected proof.
Figures
Abstract
Disruptions in purine metabolism contribute to a range of human diseases, from rare genetic disorders such as Lesch-Nyhan syndrome and xanthinuria to common conditions including gout and cancer. To better understand the metabolic networks that regulate purine homeostasis, we developed a Caenorhabditis elegans model of xanthine dehydrogenase (xdh-1) deficiency. Remarkably, xdh-1 mutant animals form rare xanthine stones, recapitulating a hallmark of human xanthinuria. To uncover genetic regulators of purine homeostasis, we performed a forward genetic screen for mutations that exacerbate xanthine stone formation in xdh-1 mutants. This approach identified multiple loss-of-function alleles in a previously uncharacterized gene, which we named gda-1. We show that gda-1 encodes an intestinal guanine deaminase that mediates a key enzymatic step in purine catabolism. The C. elegans genome also encodes a paralog, gda-2, which shares guanine deaminase activity but is expressed in distinct tissues. While gda-2 can compensate for gda-1 loss in guanine metabolism, the two genes exhibit non-redundant roles in regulating xanthine accumulation and stone formation. Interestingly, our evolutionary analyses suggest that gda-2 was acquired by nematodes via horizontal gene transfer from bacteria. These findings reveal a spatially regulated purine catabolism pathway in C. elegans and suggest that acquisition of bacterial genes has shaped a core nematode metabolic network.
Purines are essential molecules used to build DNA and support many cellular processes. When purine metabolism is disrupted, harmful compounds can accumulate and contribute to diseases such as gout and kidney stones. To better understand how animals maintain purine balance, we studied microscopic worms that can develop xanthine stones similar to those found in people with the rare disease xanthinuria. Using genetics, biochemistry, and evolutionary analyses, we identified two related enzymes that help break down purines and prevent the accumulation of potentially harmful metabolites. Although these genes encode similar enzymes, they function in different tissues and work together to maintain metabolic balance across the animal. Unexpectedly, we found that one of these genes likely originated in bacteria and entered the nematode lineage through horizontal gene transfer, a process in which genes move between unrelated species. Our findings reveal that a bacterial gene acquired millions of years ago became integrated into a fundamental animal metabolic pathway, illustrating how horizontal gene transfer can reshape core aspects of animal physiology.
Citation: Bhattacharya S, Fischer L, Fer E, Snoozy J, Hagedorn GN, Herde M, et al. (2026) Paralogous guanine deaminases acquired from bacteria by horizontal gene transfer promote purine homeostasis in Caenorhabditis elegans. PLoS Genet 22(11):
e1012379.
https://doi.org/10.1371/journal.pgen.1012379
Editor: Giovanni Bosco, Geisel School of Medicine at Dartmouth, UNITED STATES OF AMERICA
Received: July 23, 2026; Accepted: October 25, 2026; Published: November 10, 2026
Copyright: © 2026 Bhattacharya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Whole genome sequencing data for C. elegans strains have been deposited at the NIH Sequence Read Archive (SRA) under accession PRJNA1521815. All additional data are included in the manuscript and Supporting information Files.
Funding: This work was funded by the National Institutes of Health (NIH) National Institute of General Medical Sciences (R35GM146871 to KW), an NSF REU (1756912 to GH), the UW-Madison Alumni Foundation Hiroshi-Sugiyama Fund (EF), the UW-Madison Bacteriology Department Peterson Fellowship (EF), and a NASA Astrobiology Program Grant (NNH23ZDA001N-EXO to BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Life depends on intricate metabolic networks that not only sustain cellular function but also evolve in response to shifting environments and ecological pressures. These networks are dynamic systems, shaped by evolutionary forces such as gene duplication, divergence, and, in some cases, horizontal gene transfer (HGT) [1,2]. Such evolutionary processes enable organisms to adapt to changing nutrient landscapes, yet the extent to which HGT contributes to core metabolic pathways in animals remains poorly understood.
Horizontal gene transfer, the movement of genetic material between unrelated organisms, contrasts with the traditional vertical inheritance of genes from parent to offspring. While HGT is common among prokaryotes and underlies phenomena such as the spread of antibiotic resistance [3], its occurrence in animals is considered rare. Nevertheless, striking examples reveal that HGT can profoundly impact animal biology: it has enabled beetles to exploit novel nutrient sources [4], empowered predator evasion in aphids [5], and enhanced stress tolerance, plant parasitism, and nutrient acquisition in nematodes [6–9], among other cases. These examples represent evolutionary leaps, where organisms have acquired biochemical solutions from entirely different domains of life. These rare but transformative events raise fascinating questions about how such genes integrate into existing networks.
Purine metabolism provides a useful context to explore these questions. This pathway governs nucleotide turnover and energy balance, and its disruption underlies a spectrum of human disorders, from rare genetic diseases such as Lesch-Nyhan syndrome and xanthinuria to common conditions including gout and cancer [10–13]. The purine catabolic pathway in humans culminates in the oxidation of xanthine to uric acid by xanthine dehydrogenase (XDH, Fig 1A) [14]. Loss of XDH activity in humans causes xanthinuria, characterized by excessive xanthine accumulation, stone formation, and sometimes renal failure [15,16]. Although the enzymology of purine catabolism is well described, less is known about how these steps are integrated across tissues and how organisms compensate when key reactions are disrupted. Model organisms offer powerful systems to address these gaps.
Fig 1. gda-1/Y48A6B.7 inhibited the accumulation of xanthine.
A) Simplified schematic of purine catabolism in C. elegans, highlighting the roles of purine nucleoside phosphorylase (PNP-1) and xanthine dehydrogenase (XDH-1). B) Xanthine stone formation in C. elegans carrying various gda-1 mutant alleles (rae303, rae304, rae335, rae336), xdh-1(ok3234), and double mutants combining xdh-1 with gda-1 alleles. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; **, p < 0.01; ****, p < 0.0001; ordinary one-way ANOVA, Dunnett’s multiple comparison test. C) Structure of the gda-1 gene. Boxes represent exons; connecting lines indicate introns. rae303 and rae304 are chemically induced alleles identified in a screen for mutations that enhance xanthine stone formation in an xdh-1(ok3234) background. rae335 and rae336 are CRISPR/Cas9-generated deletions. The region of the gene encoding the cytosine deaminase domain is annotated (orange). Scale bar: 100 bp. D) Differential interference contrast images showing a xanthine stone in the posterior intestine of a gda-1; xdh-1 young adult C. elegans. The arrowhead marks the xanthine stone; “+” indicates the intestinal lumen; “-” indicates the rectum. Scale bars: 100 μm (upper) and 50 μm (lower). E) Quantification of xanthine in wild-type, xdh-1, gda-1, and gda-1; xdh-1 mutant young adult C. elegans. Each data point represents a biological replicate, and values are normalized to the wild type. ns, not significant; *, p < 0.05; **, p < 0.01; ordinary one-way ANOVA, Tukey’s multiple comparison test. Note, these data are derived from the same experiment displayed in S8 Fig. F) Xanthine stone formation in various mutant C. elegans was assessed. Data points represent biological replicates. Mean and standard deviation are displayed. ****, p < 0.0001; ordinary one-way ANOVA, Dunnett’s multiple comparison test. Sample size and individuals scored per biological replicate are provided in S1 Table.
https://doi.org/10.1371/journal.pgen.1012379.g001
Here, we leverage the genetic tractability of the nematode Caenorhabditis elegans to dissect purine homeostasis in vivo. Using an xdh-1 mutant that recapitulates a hallmark of human xanthinuria, xanthine stone formation, we performed a genetic screen to identify modifiers of purine metabolism [17]. This approach revealed loss-of-function mutations in gda-1, an intestinal guanine deaminase, and prompted investigation of its highly similar paralog, gda-2. Although both enzymes share guanine deaminase activity, they exhibit distinct tissue expression and non-redundant roles in purine flux. Strikingly, phylogenetic analyses suggest that gda-2 originated via horizontal gene transfer from bacteria, revealing that nematodes have incorporated a microbial enzyme into a core metabolic network. Together, these results identify previously unrecognized regulators of purine homeostasis and reveal that one component of this metabolic network likely originated through horizontal gene transfer from bacteria.
Results
gda-1/Y48A6B.7 inhibited the accumulation of xanthine
To better understand mechanisms of purine homeostasis, we previously established a C. elegans model of human xanthinuria, a rare disease caused by inactivation of xanthine dehydrogenase and characterized by elevated levels of xanthine in blood and urine, accumulation of xanthine kidney stones, and renal failure [15,17]. C. elegans with a null mutation in the gene encoding for xanthine dehydrogenase, xdh-1, develop highly autofluorescent xanthine stones. However, these stones are rare, only developing in about 2% of xdh-1 mutant animals [17]. This result is surprising given the central role of XDH-1 in the catabolism of purines and suggests alternate mechanisms for the maintenance of purine homeostasis (Fig 1A).
To identify additional genetic regulators of purine homeostasis, we performed an unbiased genetic screen for mutations that enhanced the penetrance of xanthine stone formation in xdh-1 mutant animals. We mutagenized xdh-1 mutant C. elegans with ethyl methane sulfonate (EMS) and cultured the newly mutagenized animals for two generations allowing newly induced mutations to become homozygous [18]. Individual mutagenized F2 animals were isolated and screened to identify strains in which a high fraction of F3 progeny developed xanthine stones. This screen previously revealed five loss-of-function mutations in sulp-4, a sulfate permease that negatively regulates xanthine stone accumulation in parallel to the activity of xdh-1 [17].
Here we describe two new EMS-induced recessive loss-of-function mutations, rae303 and rae304, that caused a high penetrance of xanthine stone formation in the posterior lumen of the C. elegans intestine when combined with an xdh-1 mutation (Fig 1B–1D). These mutations were prioritized because they displayed strong enhancement of xanthine stone formation and formed a complementation group, indicating they affect a single gene (see Materials and Methods). To identify the causative genetic lesions in these new mutant strains, genomic DNA was isolated and analyzed via whole genome sequencing. Given that the rae303 and rae304 mutations fail to complement one another, we predicted that these mutant strains should each have a novel EMS-induced mutation in a common gene. Upon bioinformatic analysis of our whole genome sequencing, only one gene was uniquely impacted in both mutant strains, gda-1/Y48A6B.7, strongly suggesting that these mutations in gda-1 were causative for the enhanced penetrance of xanthine stone formation in xdh-1 mutant animals (Fig 1C). rae303 was a nonsense allele of gda-1 that encoded a premature stop codon in place of glutamine at amino acid 118 (chromosome III, position 11025882, G > A, Q118*). rae304 was a missense allele which encoded a tyrosine in place of a histidine residue at amino acid position 65 (chromosome III, position 11026349, G > A, H65Y, Fig 1C). Given that rae303 and rae304 were recessive mutations and rae303 caused a premature stop codon, we propose that rae303 and rae304 encode strong loss-of-function or null alleles of gda-1.
To test the hypothesis that loss of gda-1 caused enhanced xanthine stone formation in an xdh-1 mutant background, we used CRISPR/Cas9 to engineer new gda-1 deletion alleles, rae335 and rae336. The gda-1(rae335) and gda-1(rae336) alleles were a 555 bp deletion (with a 38 bp insertion) and a 556 bp deletion respectively. rae335 and rae336 eliminate most of exon 1, all of intron 1, and part of exon 2. These deletions remove most of a predicted deaminase domain encoded by gda-1 as well as histidine 65 which is predicted to coordinate a catalytically essential zinc ion (Fig 1C) [19]. Thus, we propose that rae335 and rae336 encode null alleles of gda-1. Both gda-1(rae335) and gda-1(rae336) strongly enhanced the penetrance of xanthine stone formation caused by xdh-1 inactivation, phenocopying the gda-1 alleles isolated from our forward genetic screen (Fig 1B). We conclude that gda-1 is necessary for preventing the accumulation of xanthine stones in C. elegans also carrying an xdh-1 mutation. Interestingly, the gda-1 or xdh-1 mutations do not induce substantial xanthine stone formation on their own, demonstrating that gda-1 and xdh-1 act in parallel genetic pathways to limit xanthine stone formation (Fig 1B). We use rae336 as our gda-1 reference allele.
We wanted to understand if the dramatic enhancement of xanthine stone formation caused by gda-1 inactivation was reflective of a parallel increase in whole-animal xanthine content. To determine the impact of gda-1 inactivation on xanthine levels, we employed HPLC-MS to measure xanthine in C. elegans extracts. We measured xanthine in wild-type, xdh-1, gda-1, and gda-1; xdh-1 mutant young-adult animals. Surprisingly, xdh-1 single mutant animals did not have significantly elevated xanthine compared to the wild type. However, we observed a substantial 4-fold increase in xanthine in gda-1 single mutant C. elegans that was also present in the gda-1; xdh-1 double mutant animals (Fig 1E). These data demonstrate that gda-1 is necessary for preventing the accumulation of xanthine. Intriguingly, despite no difference in the accumulation of xanthine between gda-1 and gda-1; xdh-1 double mutant animals, we observed a dramatic difference in the formation of xanthine stones between these two strains (Fig 1B, 1E). These results indicate that elevated xanthine alone is not sufficient to promote xanthine stone formation and suggest that additional factors modulate stone development.
To genetically dissect the nature of the xanthine stones that develop in gda-1; xdh-1 animals, we introduced a mutation in pnp-1 which encodes the C. elegans purine nucleoside phosphorylase [17,20]. PNP-1 cleaves the nucleosides inosine or guanosine by phosphorolysis into ribose-1-phosphate and the bases hypoxanthine or guanine, metabolic steps required for xanthine formation (Fig 1A). To test the model that pnp-1 was necessary for the formation of xanthine stones in gda-1; xdh-1 mutant animals, we generated gda-1; pnp-1 xdh-1 triple mutant animals and assayed the formation of xanthine stones. gda-1; pnp-1 xdh-1 triple mutant animals did not develop xanthine stones (Fig 1F). These data support our model that xanthine produced downstream of PNP-1 is the critical component of the fluorescent stones we observe in our gda-1; xdh-1 double mutant animals. Although, we cannot exclude the possibility that other PNP-1-derived metabolites (hypoxanthine or guanine) also contribute to stone formation.
pnp-1 loss of function also suppresses the enhanced formation of xanthine stones caused by sulp-4 inactivation [17]. xdh-1; sulp-4 double mutant C. elegans develop xanthine stones while pnp-1 xdh-1; sulp-4 triple mutants do not. Loss of sulfur amino acid catabolism also suppresses xanthine stone formation in xdh-1; sulp-4 animals, likely by preventing excessive sulfate accumulation that drives osmotic imbalance and promotes stone development [17]. To test whether sulfur amino acid metabolism impacts xanthine stone formation in gda-1; xdh-1 animals, we constructed gda-1; xdh-1; cdo-1 triple mutant animals. cdo-1 encodes C. elegans cysteine dioxygenase, a critical enzyme in sulfur amino acid breakdown [21]. Loss of cdo-1 did not impact xanthine stone formation in gda-1; xdh-1 mutant animals (S1 Fig). The distinct genetic requirements for cdo-1 in xanthine stone enhancement caused by sulp-4 versus gda-1 loss of function suggests that these genetic enhancers are not equivalent and likely involve distinct pathways.
gda-1 encoded a guanine deaminase that acted in the intestine
gda-1 is predicted to encode a 168 amino acid deaminase and shares 47% amino acid identity with a well-characterized guanine deaminase (GDA) from the bacteria Bacillus subtilis (BsGDA, WP_367147857, Fig 2A) [22,23]. GDA enzymes catalyze the hydrolytic deamination of guanine, producing xanthine and ammonia. Given the reaction catalyzed by GDA enzymes, it is counterintuitive that loss of a guanine deaminase would lead to accumulation of its product, xanthine. Nevertheless, key substrate-binding and catalytic residues are conserved between BsGDA and GDA-1 in C. elegans (Fig 2A) [19]. Interestingly, the rae304 lesion isolated in our forward genetic screen alters histidine 65, corresponding to histidine 53 in BsGDA, that resides in the active site of the enzyme and coordinates the catalytically essential zinc ion (Fig 2A) [19]. Thus, rae304 (H65Y) likely disrupts zinc coordination of the GDA-1 active site, reducing or eliminating the activity of the enzyme. Based on this homology we hypothesize that the gda-1/Y48A6B.7 genetic locus encodes a C. elegans guanine deaminase.
Fig 2. gda-1 encoded a guanine deaminase that acted in the intestine.
A) Amino acid alignment of the cytosine deaminase domain of C. elegans GDA-1 (NP_499418.1), GDA-2 (NP_498663.1), and B. subtilis GDA (WP_367147857.1). The catalytically essential histidine 65 (GDA-1) is highlighted in red. Glutamine 118 which was impacted by the rae303 allele is highlighted in yellow. Active site and substrate binding residues are highlighted in blue. “*” indicates perfect amino acid conservation, “:” indicates strong similarity, and “.” indicates weak similarity amongst sequences compared. B) Differential interference contrast (left) and fluorescence microscopy (right) images of gda-1; xdh-1 mutant animals expressing the Pgda-1::GFP::GDA-1 transgene. GFP::GDA-1 localizes to the cytoplasm and nuclei (highlighted with yellow circles) of intestinal cells. Scale bars: 25 μm. C) Schematic of the Pgda-1::GFP::GDA-1 transgene, which encodes wild-type GDA-1 fused to GFP at the N-terminus. Exons are shown as boxes, introns as connecting lines, and the 985 bp gda-1 promoter as a straight line. Scale bar: 100 bp. D) Transgenic gda-1; xdh-1 animals expressing either wild-type (Pgda-1::GFP::GDA-1[WT]) or catalytically inactive (Pgda-1::GFP::GDA-1[H65A]) GDA-1, along with their non-transgenic siblings, were scored for xanthine stone formation. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; *, p < 0.05; **, p < 0.01; t test. E) Schematic of the Pgda-1::GFP::BsGDA transgene, which encodes wild-type B. subtilis GDA fused to GFP at the N-terminus. Exons are shown as boxes, introns as connecting lines, and the 985 bp gda-1 promoter as a straight line. Scale bar: 100 bp. F) Transgenic gda-1; xdh-1 animals expressing either wild-type (Pgda-1::GFP::BsGDA[WT]) or catalytically inactive (Pgda-1::GFP::BsGDA[H53A]) GDA, along with their non-transgenic siblings, were scored for xanthine stone formation. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; *, p < 0.05; **, p < 0.01; t test. Complete details on sample size and individuals scored per biological replicate are provided in S1 Table.
https://doi.org/10.1371/journal.pgen.1012379.g002
To determine the site of GDA-1 action, we engineered a wild-type GDA-1 transgene with an N-terminal green fluorescent protein (GFP) fusion driven by the native gda-1 promoter (Pgda-1::GFP::GDA-1[WT], Fig 2B, 2C). Transgenic gda-1; xdh-1 double mutant animals expressing Pgda-1::GFP::GDA-1 were generated and were analyzed for GFP::GDA-1 expression [24]. GFP::GDA-1 expression was detected exclusively in the C. elegans intestine and appeared to be present in both the cytoplasmic and nuclear compartments, based on comparison of GFP fluorescence and corresponding differential interference contrast images (Fig 2B). Importantly, the Pgda-1::GFP::GDA-1 transgene rescued the formation of xanthine stones in gda-1; xdh-1 double mutants in three independent transgenic lines, strongly suggesting that the intestinal GFP::GDA-1 localization represents the native GDA-1 expression pattern (Fig 2D). We conclude that GDA-1 is expressed and acts in the intestine to limit the formation of xanthine stones.
To genetically test the hypothesis that GDA-1 is a guanine deaminase, we attempted to rescue gda-1 loss of function with the well characterized guanine deaminase BsGDA from the bacterium B. subtilis. We engineered a transgene expressing BsGDA with an N-terminal GFP fusion expressed by the native C. elegans gda-1 promoter (Pgda-1::GFP::BsGDA[WT], (Fig 2E) [19,25]. Transgenic gda-1; xdh-1 double mutant animals expressing Pgda-1::GFP::BsGDA were generated and analyzed for the formation of xanthine stones. GFP::BsGDA was expressed in the intestine and sufficient to rescue the formation of xanthine stones in gda-1; xdh-1 double mutant animals in three independent transgenic lines (Fig 2F).
To determine if rescue via Pgda-1::GFP::GDA-1 or Pgda-1::GFP::BsGDA was dependent upon a catalytically active deaminase, we engineered Pgda-1::GFP::GDA-1[H65A] and Pgda-1::GFP::BsGDA[H53A] constructs in which we altered the catalytically essential histidine in the active site of each enzyme. Transgenic gda-1; xdh-1 double mutant animals expressing either Pgda-1::GFP::GDA-1[H65A] or Pgda-1::GFP::BsGDA[H53A] developed xanthine stones similar to their non-transgenic siblings, demonstrating that the catalytic histidine was necessary to rescue the xanthine stone phenotype displayed by gda-1; xdh-1 animals (Fig 2D, 2F). We observed similar GFP::GDA-1 levels between the wild-type and H65A transgenes, although the GFP::GDA-1[H65A] lines displayed increased mosaicism, which may partially account for the corresponding variability in xanthine stone penetrance (Figs 2D and S2A, S2B). We observed GFP::BsGDA expression in both wild-type and H53A variants of the transgene, although we note that GFP levels appear reduced in the H53A variant (S2C, S2D Fig). Together, these data support the model that the previously uncharacterized Y48A6B.7 genetic locus encodes a C. elegans guanine deaminase, which we have named gda-1 [19,25].
gda-2 encoded a guanine deaminase paralogous to gda-1
The C. elegans genome encodes a gene (R13A5.10) paralogous to gda-1 which we name gda-2. GDA-1 and GDA-2 display 66% identity at the amino acid sequence level and complete conservation of catalytically essential residues (Fig 2A) [19,23]. Despite this sequence conservation, gda-1 and gda-2 were not functionally redundant with respect to the limiting xanthine stone formation in an xdh-1 mutant background; gda-1; xdh-1 double mutant animals displayed xanthine stones even though a wild-type copy of gda-2 was present in the genome (Fig 3A). Furthermore, gda-2 loss of function did not enhance the formation of xanthine stones in an xdh-1 mutant background and did not promote xanthine accumulation (Fig 3A, 3B).
Fig 3. gda-2 encoded a guanine deaminase paralogous to gda-1.
A) Xanthine stone formation in various mutant C. elegans was assessed. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; ****, p < 0.0001; ordinary one-way ANOVA, Dunnett’s multiple comparison test. B) Quantification of xanthine in wild-type and various mutant young adult C. elegans. Each data point represents a biological replicate, and values are normalized to the wild type. ns, not significant; ****, p < 0.0001; ordinary one-way ANOVA, Šidák’s multiple comparison test. Note, these data are derived from the same experiment displayed in S8 Fig. C) Schematic of the Pgda-1::GFP::GDA-2 transgene, which encodes wild-type GDA-2 fused to GFP at the N-terminus. Exons are shown as boxes, introns as connecting lines, and the 985 bp gda-1 promoter as a straight line. Scale bar: 100 bp. D) Transgenic gda-1; xdh-1 animals expressing wild-type GDA-2 driven by the gda-1 promoter (Pgda-1::GFP::GDA-2), along with their non-transgenic siblings, were scored for xanthine stone formation. Data points represent biological replicates. Mean and standard deviation are displayed. **, p < 0.01; ****, p < 0.0001; t test. Complete details on sample size and individuals scored per biological replicate are provided in S1 Table.
https://doi.org/10.1371/journal.pgen.1012379.g003
Given the striking similarity between GDA-1 and GDA-2 amino acid sequences, we hypothesized that gda-2 encodes an enzyme with guanine deaminase activity, like gda-1. To determine if GDA-2 and GDA-1 were functionally interchangeable, we engineered a transgene expressing GDA-2 with an N-terminal GFP tag under the control of the gda-1 promoter (Pgda-1::GFP::GDA-2) (Fig 3C). We sought to test if expressing GDA-2 in the intestine under the control of the gda-1 promoter was sufficient to rescue gda-1 loss-of-function. We generated transgenic gda-1; xdh-1 double mutant C. elegans expressing the Pgda-1::GFP::GDA-2 transgene and assessed the formation of xanthine stones in three independent transgenic lines. gda-1; xdh-1 mutant animals expressing Pgda-1::GFP::GDA-2 did not develop xanthine stones, demonstrating functional rescue (Fig 3D). These data demonstrate that gda-2 is sufficient to rescue gda-1 mutant loss of function when expressed in the intestine, the site of gda-1 activity. We suggest that gda-1 and gda-2 are functionally interchangeable paralogs that both encode enzymes with guanine deaminase activity.
gda-1 and gda-2 acted redundantly to promote guanine deamination in C. elegans
To further test the model that GDA-1 and GDA-2 are guanine deaminases, we measured guanine levels in wild-type, gda-1, gda-2, and gda-2 gda-1 mutant C. elegans. gda-1 and gda-2 single mutant C. elegans did not accumulate significantly more guanine when compared to the wild type (Fig 4A). However, gda-2 gda-1 double mutant animals accumulated 67-fold more guanine than wild type, dramatically increased compared to either gda-1 or gda-2 single mutant animals alone (Fig 4A). Additionally, gda-2 gda-1 double mutant animals developed dull autofluorescent stones, distinct in fluorescent character from the bright xanthine stones observed in gda-1; xdh-1 double mutant animals (Fig 4B-4G). Given that gda-2 gda-1 double mutant animals hyperaccumulate guanine and lack xanthine, we propose that these dull autofluorescent stones are likely to be guanine stones (Figs 3B and 4A). Consistent with this model, fluorescent imaging of pure guanine and xanthine revealed similar fluorescent character to the guanine and xanthine stones we observe in our C. elegans genetic models (S3 Fig). Furthermore, formation of autofluorescent stones in gda-2 gda-1 double mutant animals required pnp-1 activity, which catalyzes the production of guanine from guanosine (Figs 1A, 4B). Taken together, these data are consistent with the model that GDA-1 and GDA-2 are guanine deaminases that act redundantly to limit the accumulation of guanine in C. elegans.
Fig 4. gda-1 and gda-2 acted redundantly to limit guanine accumulation.
A) Quantification of guanine in wild-type, gda-1, gda-2, and gda-2 gda-1 mutant young adult C. elegans. Each data point represents a biological replicate, and values are normalized to the wild type. ns, not significant; ****, p < 0.0001; ordinary one-way ANOVA, Tukey’s multiple comparison test. Note, these data are derived from the same experiment displayed in S8 Fig. B) Guanine stone formation in single, double, and triple mutant C. elegans was assessed. Data points represent biological replicates. Mean and standard deviation are displayed. ****, p < 0.0001; ordinary one-way ANOVA, Dunnett’s multiple comparison test. C-G) Brightfield (C,F) and fluorescence microscopy (D,E,G) images of the posterior section of gda-2 gda-1 (C-E) and gda-1; xdh-1 mutant animals (F,G). Pink arrowheads denote weakly autofluorescent guanine stones while yellow arrowheads denote strongly autofluorescent xanthine stones. Note, fluorescence images in D and G were captured at the same exposure and are directly comparable while the image in E was captured with a higher exposure to reveal the weakly autofluorescent guanine stones. Scale bars: 100 μm. H) Model for guanine catabolism facilitated by GDA-1 and GDA-2. During gda-1 loss of function, gda-2 acts in non-intestinal tissues to promote xanthine hyperaccumulation.
https://doi.org/10.1371/journal.pgen.1012379.g004
Critically, these data shed light on the counterintuitive observation that xanthine, the product of GDA-1-mediated guanine deamination, accumulates during gda-1 loss of function (Figs 1B and 3B). During gda-1 loss of function, guanine is deaminated at an increased rate via GDA-2. This is supported by the observation that gda-2 was necessary for the accumulation of xanthine during gda-1 loss of function (Fig 3B). In fact, gda-2 gda-1 double mutant C. elegans displayed a substantial reduction in xanthine below that observed in either gda-1 or gda-2 single mutant animals (Fig 3B). This result demonstrates that gda-2 is necessary for xanthine accumulation in the context of gda-1 loss of function (Fig 4H).
One possible explanation for gda-2-mediated xanthine accumulation in a gda-1 mutant background is that gda-2 expression increases following gda-1 inactivation. To explore this, we assessed transcriptional and post-transcriptional regulation of gda-2. We speculated that xanthine accumulation in gda-1 mutants might result from increased transcription of gda-2 or other genes involved in C. elegans purine metabolism. Yet, gda-1 inactivation did not promote mRNA accumulation of any of the purine metabolic genes tested via quantitative PCR (S4A Fig). This suggests that gda-2 activity is not controlled at the level of transcription or mRNA stability. To test the hypothesis that GDA-2 protein levels may be increased during gda-1 inactivation, we quantified GFP::GDA-2 levels driven by a Pgda-2::GFP::GDA-2 transgene in both wild-type and gda-1 mutant C. elegans (S4B, S4C Fig). We observed that GFP::GDA-2 levels were not reliably increased during gda-1 inactivation using two independent Pgda-2::GFP::GDA-2 transgenes. Thus, neither gda-2 mRNA nor protein accumulate during gda-1 loss of function. Further studies are required to determine whether GDA-2 activity may be controlled via unknown regulators or posttranslational modifications.
gda-1 inactivation reduced fecundity in a pnp-1 and gda-2-dependent manner
We investigated whether purine dyshomeostasis resulting from gda-1 loss of function compromises C. elegans fitness. To test this, we analyzed developmental rate, embryonic hatching, and brood size for wild-type and gda-1 single mutant C. elegans. We observed no defects in larval development or embryonic hatching but found that gda-1 mutant animals displayed a ~ 34% decrease in brood size compared to the wild type (S5 Fig). These data demonstrate that gda-1 promotes reproductive fitness in C. elegans. Interestingly, this reduction in brood size was dependent upon functional pnp-1 and gda-2; both gda-1; pnp-1 and gda-2 gda-1 double mutant C. elegans exhibited higher brood sizes when compared to gda-1 single mutant animals (S5C Fig). Thus, pnp-1 and gda-2 activity limit fecundity when gda-1 is inactive. These data mirror our results with xanthine accumulation; xanthine accumulates in gda-1 mutant animals in a pnp-1 and gda-2-dependent manner (Figs 1F, 3B). This correlation suggests xanthine accumulation may limit fecundity in C. elegans, although this model remains to be rigorously tested.
gda-2 was expressed and likely acted in multiple tissues to promote guanine deamination
What might explain the maintenance of functionally interchangeable gda paralogs in the C. elegans genome? We speculated that these paralogs may both provide a fitness advantage through expression in distinct, functionally relevant tissues. gda-1 was exclusively expressed in the intestine of C. elegans (Fig 2B). We hypothesized that gda-2 would act in non-intestinal tissues to maintain purine homeostasis. To determine the site of action for gda-2, we engineered a gda-2-expressing transgene with an N-terminal GFP tag driven by the native gda-2 promoter (Pgda-2::GFP::GDA-2). We found that Pgda-2::GFP::GDA-2 was expressed in multiple sites including neuronal cells and the excretory cell. Notably, we did not detect Pgda-2::GFP::GDA-2 expression in the intestine (S6A Fig). Importantly, Pgda-2::GFP::GDA-2 rescued the formation of guanine stones displayed by gda-2 gda-1 double mutant animals in three independent transgenic strains (S6C Fig). As expected, the Pgda-2::GFP::GDA-2 transgene did not rescue the formation of xanthine stones displayed by gda-1; xdh-1 double mutant animals (S6B Fig). We conclude that gda-1 and gda-2 are acting in distinct tissues to facilitate guanine deamination.
To identify the primary site of action for GDA-2, we performed tissue specific rescue experiments. GFP::GDA-2 was expressed under the control of the sng-1 (neurons), vha-6 (intestine), myo-3 (muscle), col-10 (hypodermis), or sulp-4 (excretory cell) tissue-specific promoters and assessed for ability to rescue the formation of guanine stones displayed by gda-2 gda-1 double mutant C. elegans. Expression of GFP::GDA-2 in the intestine was sufficient to rescue the formation of guanine stones in gda-2 gda-1 mutant animals (S6C Fig). This result was anticipated given that gda-1 and gda-2 are functionally interchangeable and that gda-1 acts in the intestine. Thus, this result reflects that the Pvha-6::GFP::GDA-2 transgene is rescuing gda-1 loss of function. Expression of GFP::GDA-2 in any of the other individual tissues (neurons, muscle, hypodermis, or excretory cell) alone did not provide consistent and substantial rescue of guanine stones in gda-2 gda-1 mutant animals (S6C Fig). We note that expression of GFP::GDA-2 in the excretory cell, a site of native expression, showed a non-significant trend toward reduced guanine stone penetrance. However, the variability of the data limits a conclusive assessment of excretory cell-specific GFP::GDA-2 function, which will require future studies. All transgenic strains expressed GFP::GDA-2 in the expected tissues (S7 Fig). We conclude that gda-2 is likely acting in multiple tissues to promote guanine deamination.
Impact of gda-1, gda-2, and xdh-1 on purine metabolite levels in C. elegans
To obtain a more comprehensive view of how gda-1, gda-2, and xdh-1 shape purine metabolism in C. elegans, we quantified additional purine intermediates (adenosine, guanosine, xanthosine, inosine, hypoxanthine, uric acid, and allantoin) in wild-type and mutant animals (S8A Fig). As expected, uric acid and allantoin were nearly undetectable in all strains lacking xdh-1. This is consistent with the essential role of XDH-1 in uric acid production and with uric acid serving as the precursor for allantoin synthesis, presumably via an unidentified C. elegans uricase [26]. Loss of both gda-1 and gda-2 caused a substantial accumulation of the nucleoside guanosine, mirroring the accumulation of the corresponding base, guanine (S8A Fig). We propose that this buildup reflects reversal of the PNP-1 reaction under condition of guanine excess, shifting metabolic flux back toward the nucleoside. In contrast, xanthine was nearly undetectable in gda-2 gda-1; xdh-1 triple mutant animals, indicating that all enzymatic routes of xanthine production were genetically eliminated (S8A Fig). Despite this, these triple mutant animals developed bright autofluorescent stones similar to those in gda-1; xdh-1 double mutants (S9 Fig). We speculate that these stones are composed of a distinct, unknown autofluorescent metabolite. These findings suggest that autofluorescence alone is not diagnostic of xanthine stone formation and emphasize the importance of integrating genetic, metabolic, and imaging data when considering the identity of metabolic stones. Finally, absolute metabolite quantification in wild-type animals revealed that guanine was present at extremely high levels, ~ 900-fold more abundant than the next most common metabolite measured, allantoin (S8B Fig). The potential physiological significance of this striking guanine abundance is considered in the Discussion.
gda-2 was likely acquired via horizontal gene transfer from Bacillota
There are two classes of guanine deaminases present across the tree of life. The cytidine deaminase-like family, exemplified by B. subtilis GDA, and the amidohydrolase family, exemplified by E. coli GuaD [19,27,28]. These enzymes are distinct in size, domain architecture, and active site composition [19,27,29]. To examine the distribution of the two guanine deaminase families across the animal tree of life, we used BLASTp to search the NCBI ClusteredNR sequence database with the amino acid sequences from B. subtilis GDA (WP_043857361) or E. coli GuaD (CAD6004693.1). We then calculated the mean bit score from the top 50 (where available) hits for representative animal phylum and superphylum (Fig 5A) [23,30]. Intriguingly, we see the presence of the amidohydrolase family of guanine deaminases (E. coli GuaD-like) across the animal tree of life with the notable exception of the nematode lineage (Fig 5A). For example, human guanine deaminase is homologous to the E. coli GuaD amidohydrolase [31]. In contrast, we only observe strong evidence of the B. subtilis-like guanine deaminase among nematodes (Fig 5A). These data suggest nematodes are unique among animals in their use of a cytidine deaminase-like guanine deaminase.
Fig 5. gda-2 was likely acquired via horizontal gene transfer from Bacillota.
A) Cartoon of the animal tree of life (left). The heat map (right) displays the mean BLASTp bit scores using B. subtilis GDA and E. coli GuaD as queries within each phylum or superphylum. Number of bit scores considered are displayed in parentheses. B) A maximum likelihood gene tree of 257 GDA homologs from 30 nematodes and 207 prokaryotes. The taxa were collapsed and colored at phylum-level. The branch support values (UFBoot2) are indicated by circles: black for 95–100, gray for 90–94, or white for 85–89. A zoomed-in view of the nematode group is shown on right. C) Species tree (Open Tree of Life) with 237 taxa is collapsed and colored based on phylum. A horizontal gene transfer event from Bacillota to the ancestral branch of Nematoda is shown with an inferred transfer rate of 0.45 as calculated by ALE.
https://doi.org/10.1371/journal.pgen.1012379.g005
Given the intriguing evolutionary pattern of guanine deaminases among animals (Fig 5A), we investigated the evolutionary origins of the nematode GDAs. A BLASTp search against the NCBI ClusteredNR sequence database revealed that the closest matches to C. elegans GDA-1 or GDA-2 (highest bit score) were nematode sequences. Outside of nematodes, the most significantly related sequences were all bacterial or archaeal in origin, suggesting a close evolutionary relationship. Based on this pattern of homology, we hypothesized that gda-1 or gda-2 entered the nematode lineage via interdomain horizontal gene transfer, rather than by conventional vertical inheritance. This model is consistent with a prior genome-wide analysis of HGT in C. elegans that identified gda-1 or gda-2 as candidate HGT-derived genes [32]. We sought to test this model given that bioinformatically predicted HGT events do not always withstand individualized scrutiny [33].
To test the HGT model, we identified homologs of GDA-1 and GDA-2 across 30 nematode genomes and 207 prokaryotic genomes and constructed a maximum-likelihood phylogeny. Nematode GDA sequences clustered closely with a subset of Bacillota, supporting a bacterial origin (Fig 5B). Within nematodes, Caenorhabditis GDA homologs formed two well-supported clades (UFBoot 96–99), suggesting a duplication event gave rise to the paralogous gda-1 and gda-2 within Caenorhabditis. In contrast, other nematodes with multiple GDA copies grouped together, indicative of more recent duplication events (Fig 5B). Notably, the Caenorhabditis GDA-2 clade branched earlier than GDA-1 suggesting that GDA-2 likely represents the ancestral copy (Fig 5B).
To test for discordance between our maximum-likelihood phylogeny and the tree of life, we performed gene-tree species-tree reconciliation. This analysis inferred a single HGT event from Bacillota into the ancestor of all nematodes (ALE rate = 0.45) whereas other potential HGT events were inferred at low rates (ALE rate ~0.01, Fig 5C). These results support a scenario in which the ancestral nematode gene (gda-2) was acquired from Bacillota (possibly a close relative of Enterococcus silesiacus), followed by duplication in the Caenorhabditis lineage and subsequent diversification. Given the abundance of E. coli GuaD-like enzymes in the animal lineage and absence among nematodes (Fig 5A), we propose that gda-2 entered the nematode lineage via HGT causing the evolutionary loss of the typical animal guanine deaminase.
Together, our genetic, biochemical, and phylogenetic studies suggest that a guanine deaminase gene from Bacillota entered the nematode lineage via HGT. This gene duplicated, giving rise to gda-1 and gda-2, which subsequently diverged to function in distinct tissues. Our findings trace the evolutionary arc of this transfer and reveal how these acquired genes became integral components of the nematode purine catabolic pathway.
Discussion
Purine metabolism is coordinated across multiple tissues in C. elegans
Our findings indicate that guanine deamination in C. elegans is executed by a distributed metabolic system in which paralogous enzymes act in distinct tissues. GDA‑1 functions specifically in the intestine, while GDA‑2 likely operates across multiple non‑intestinal tissues, revealing that purine catabolism is spatially organized rather than confined in a cell-autonomous manner. This view is consistent with earlier work showing that equilibrative nucleoside transporters ENT‑1 and ENT‑2 act redundantly to promote development and reproduction [34]. More recent studies demonstrate that these transporters mediate guanosine flux from the intestine to the germline and that combined loss of ent-1 and ent-2 depletes germline guanosine, causing sterility [35]. Furthermore, the impact of nucleoside transporters on physiology extends to dietary nutrient availability; ent-4 encodes an intestinal nucleoside transporter governing dietary nucleoside transport which modulates proteosome function [36]. Collectively, these studies establish that the intestine plays a central role in generating and distributing purine metabolites across tissues.
Within this framework, the distinct consequences of losing GDA‑1 versus GDA‑2 suggest that guanine, guanosine, xanthine, and related intermediates likely participate in similar inter‑tissue transport. The brood‑size reduction observed in gda‑1 mutants may therefore reflect not only xanthine accumulation but also altered delivery of guanine‑derived nucleosides to metabolically demanding tissues such as the germline. The sensitivity of germline proliferation to somatically supplied purines and the compensatory rewiring of purine biosynthesis observed in ENT‑deficient animals further reinforce this possibility [35].
Together, these findings support a model in which purine metabolism in C. elegans is inherently multi‑tissue, relying on both localized enzymatic processing and transporter‑mediated metabolite exchange. As this network is likely more complex than currently appreciated, future work examining how perturbations in transport and enzymatic pathways interact will help clarify the spatial logic of purine homeostasis.
Loss of intestinal gda‑1 causes unexpected xanthine accumulation
A central feature of our data is that gda‑1 mutants accumulate more xanthine than wild type, even though they lack the major intestinal guanine deaminase. Our proposed model is that loss of intestinal GDA‑1 causes guanine to build up and redistribute into distal tissues, where it becomes available to GDA‑2 (Fig 4H). While we do not observe regulation of gda-2 mRNA or protein levels, reaction rates may simply increase with substrate concentration. Thus, elevated regional guanine could increase GDA‑2 activity even without changes in gda‑2 expression.
However, substrate availability alone does not explain why xanthine, the product, accumulates. A simple extension of the model is that distal tissues may possess lower XDH‑1 activity, producing xanthine faster than it can be cleared. XDH-1 is expressed in the intestine, neurons, and excretory cell—although these tissues have yet to be functionally evaluated for roles in purine catabolism and xanthine stone formation [37]. In this view, wild‑type animals deaminate guanine primarily in the intestine, where XDH‑1 efficiently catabolizes xanthine; but when GDA‑1 is lost, deamination shifts into tissues that are less capable of processing xanthine, allowing it to accumulate.
Finally, because xanthine stones form in the intestinal lumen, xanthine must ultimately move back into the intestine, again indicating that purine intermediates are mobile across tissues. The overall model is therefore that GDA‑1 loss redistributes guanine, drives GDA‑2 activity in distal tissues, and results in excess xanthine that returns to the intestine where it crystallizes.
Evolutionary origin and functional diversification of nematode guanine deaminases
Our comparative genomics and phylogenetic analyses reveal that nematodes possess a guanine deaminase lineage with an evolutionary history distinct from that of other animals: nematodes employ a cytidine‑deaminase-like guanine deaminase whereas other animals use an amidohydrolase-family guanine deaminase that is notably absent among nematode genomes. We propose that this evolutionary pattern is parsimoniously explained by HGT. However, we cannot exclude the alternative possibility that an ancestral animal possessed both classes of guanine deaminases, followed by repeated loss of the cytidine‑deaminase-like guanine deaminase during animal evolution, with the notable exception of the nematode lineage. Supporting the HGT model, gene tree-species tree reconciliation supports a single HGT event from a Bacillota donor into the ancestral nematode lineage, introducing a cytidine‑deaminase-like guanine deaminase into nematodes. Given the absence of the animal amidohydrolase-family guanine deaminase in nematodes, we propose that the cytidine‑deaminase-like guanine deaminase acquired via HGT has functionally and evolutionarily replaced this enzyme. This evolutionary trajectory raises broader questions about how microbial enzymes become entrenched within core metabolic pathways in animals.
Horizontally transferred genes with clear functional impact are increasingly recognized across metazoans. Coffee berry borer beetles acquired a bacterial mannanase that enables them to access galactomannan, a major polysaccharide in coffee berries that was previously inaccessible [4]. Aphids acquired genes from fungi that promote carotenoid production empowering predator evasion [5]. Nematodes provide several examples of functional HGT. They acquired a bacterial gene that enables L‑rhamnose synthesis and strengthens the cuticle against environmental stresses and toxins [6]. They also acquired an algal cysl gene that allows them to sense and detoxify amygdalin‑derived cyanide, a plant defense compound lethal to most animals [7]. In addition, plant‑parasitic nematodes obtained multiple bacterial cell‑wall‑degrading enzymes that empower them to breach and exploit plant tissues [8]. These examples of HGT suggest clear fitness advantages for the recipient organism.
Our genetic and metabolic data demonstrate that GDA‑1 and GDA‑2 function as guanine deaminases. Yet the evolutionary advantage of replacing an ancestral amidohydrolase‑type enzyme with a horizontally transferred cytidine‑deaminase-like guanine deaminase is not obvious and reflects a departure from the classic model of HGT introducing novel biochemical capabilities. Clues to the evolutionary shift may be suggested by our metabolite measurements. We found that wild‑type C. elegans naturally accumulates high levels of guanine, ~ 900‑fold more than any other measured purine intermediate. Similar guanine accumulation occurs in organisms that use guanine crystals as metabolic stores or structural materials [38–41]. In fact, the dinoflagellate Amphidinium carterae possesses substantial capacity to sequester crystalline guanine, enabling the accumulation of nitrogen reserves sufficient to sustain multiple subsequent generations. These reserves are rapidly built through both direct assimilation of environmental guanine and de novo synthesis from diverse nitrogen‑containing substrates [40]. We raise the possibility that C. elegans also uses guanine as a mobilizable nitrogen reserve. This idea aligns with the species’ natural history, which includes spending a substantial portion of its life in nutrient-limited, diapause-like states [42]. Notably, B. subtilis uses guanine as a nitrogen source via a GDA enzyme highly similar with nematode GDA‑1 [25]. In fact, we demonstrate that B. subtilis GDA is functionally interchangeable with C. elegans GDA-1, suggesting that the transferred enzyme may already have been suited for this function upon arrival in the nematode lineage. We propose that the horizontally acquired cytidine‑deaminase-like guanine deaminase may have allowed nematodes to exploit guanine as an otherwise inaccessible nitrogen reserve, potentially enhancing survival during nutrient stress. This model remains speculative, and future work will be required to rigorously test it.
Taken together, our analyses support an evolutionary trajectory in which a single bacterial cytidine‑deaminase-like guanine deaminase entered the nematode lineage via HGT, followed by loss of the ancestral amidohydrolase‑family guanine deaminase. Within Caenorhabditis, the horizontally acquired gene duplicated to form gda‑1 and gda‑2, which then diverged primarily through tissue‑specific regulation rather than catalytic specialization. These paralogous enzymes evolved into the sole guanine deaminases driving purine catabolism in nematodes.
Materials and methods
General methods and strains
Caenorhabditis elegans were maintained at 20°C on nematode growth medium (NGM) plates seeded with Escherichia coli OP50, following standard procedures [18]. The wild-type reference strain used was Bristol N2. All mutant and transgenic strains used in this study are listed below. Previously described strains are cited; strains without references were generated in this study.
- Non-transgenic strains:
- N2, wild type [18]
- USD869, xdh-1(ok3234) IV [17]
- USD1044, gda-1(rae335) III; xdh-1(ok3234) IV
- USD1045, gda-1(rae336) III; xdh-1(ok3234) IV
- USD1154, xdh-1(ok3234) IV; cdo-1(mg622) X [17]
- USD1156, gda-1(rae336) III; cdo-1(mg622) X
- USD1163, pnp-1(jy121) IV, outcrossed one time [20]
- USD1164, gda-1(rae336) III; xdh-1(ok3234) IV; cdo-1(mg622) X
- USD1174, pnp-1(jy121) xdh-1(ok3234) IV [17]
- USD1176, gda-1(rae336) III; pnp-1(jy121) IV
- USD1188, gda-1(rae336) III; pnp-1(jy121) xdh-1(ok3234) IV
- USD1178, gda-2(tm10990) III, outcrossed four times
- USD1179, gda-2(tm10990) III; xdh-1(ok3234) IV
- USD1227, gda-2(tm10990) gda-1(rae336) III
- USD1201, gda-2(tm10990) gda-1(rae336) III; xdh-1(ok3234) IV
- USD1505, gda-2(tm10990) gda-1(rae336) III; pnp-1(jy121) IV
- USD1508, gda-2(tm10990) III; pnp-1(jy121) IV
- Transgenic strains:
- USD1259, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx126 [Pgda-1::GFP::GDA-1]
- USD1270, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx135 [Pgda-1::GFP::GDA-1]
- USD1271, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx136 [Pgda-1::GFP::GDA-1]
- USD1260, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx127 [Pgda-1::GFP::BsGDA]
- USD1261, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx128 [Pgda-1::GFP::BsGDA]
- USD1264, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx130 [Pgda-1::GFP::BsGDA]
- USD1265, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx131 [Pgda-1::GFP::GDA-2]
- USD1266, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx132 [Pgda-1::GFP::GDA-2]
- USD1267, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx133 [Pgda-1::GFP::GDA-2]
- USD1283, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx140 [Pgda-1::GFP::GDA-1(H65A)]
- USD1284, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx141 [Pgda-1::GFP::GDA-1(H65A)]
- USD1285, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx142 [Pgda-1::GFP::GDA-1(H65A)]
- USD1286, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx143 [Pgda-1::GFP::BsGDA(H53A)]
- USD1287, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx144 [Pgda-1::GFP::BsGDA(H53A)]
- USD1288, gda-1(rae336)III; xdh-1(ok3234)IV; raeEx145 [Pgda-1::GFP::BsGDA(H53A)]
- USD1314, gda-2(tm10990) gda-1(rae336) III; raeEx146 [Pgda-2::GFP::GDA-2]
- USD1315, gda-2(tm10990) gda-1(rae336) III; raeEx147 [Pgda-2::GFP::GDA-2]
- USD1316, gda-2(tm10990) gda-1(rae336) III; raeEx148 [Pgda-2::GFP::GDA-2]
- USD1352, gda-2(tm10990) gda-1(rae336) III; raeEx157 [Psulp-4::GFP::GDA-2]
- USD1353, gda-2(tm10990) gda-1(rae336) III; raeEx158 [Psulp-4::GFP::GDA-2]
- USD1354, gda-2(tm10990) gda-1(rae336) III; raeEx159 [Psulp-4::GFP::GDA-2]
- USD1356, gda-2(tm10990) gda-1(rae336) III; raeEx161 [Pcol-10::GFP::GDA-2]
- USD1357, gda-2(tm10990) gda-1(rae336) III; raeEx162 [Pcol-10::GFP::GDA-2]
- USD1358, gda-2(tm10990) gda-1(rae336) III; raeEx163 [Pcol-10::GFP::GDA-2]
- USD1363, gda-2(tm10990) gda-1(rae336) III; raeEx165 [Psng-1::GFP::GDA-2]
- USD1364, gda-2(tm10990) gda-1(rae336) III; raeEx166 [Psng-1::GFP::GDA-2]
- USD1365, gda-2(tm10990) gda-1(rae336) III; raeEx167 [Psng-1::GFP::GDA-2]
- USD1416, gda-2(tm10990) gda-1(rae336) III; raeEx196 [Pmyo-3::GFP::GDA-2]
- USD1417, gda-2(tm10990) gda-1(rae336) III; raeEx197 [Pmyo-3::GFP::GDA-2]
- USD1418, gda-2(tm10990) gda-1(rae336) III; raeEx198 [Pmyo-3::GFP::GDA-2]
- USD1420, gda-2(tm10990) gda-1(rae336) III; raeEx200 [Pvha-6::GFP::GDA-2]
- USD1421, gda-2(tm10990) gda-1(rae336) III; raeEx201 [Pvha-6::GFP::GDA-2]
- USD1422, gda-2(tm10990) gda-1(rae336) III; raeEx203 [Pvha-6::GFP::GDA-2]
- USD1381, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx180 [Pgda-2::GFP::GDA-2]
- USD1382, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx181 [Pgda-2::GFP::GDA-2]
- USD1383, gda-1(rae336) III; xdh-1(ok3234) IV; raeEx182 [Pgda-2::GFP::GDA-2]
- USD1328, raeEx149 [Pgda-2::GFP::GDA-2]
- USD1329, raeEx150 [Pgda-2::GFP::GDA-2]
- USD1450, gda-1(rae336) III; raeEx149 [Pgda-2::GFP::GDA-2]
- USD1451, gda-1(rae336) III; raeEx150 [Pgda-2::GFP::GDA-2]
- EMS-derived strains:
- USD972, xdh-1(ok3234) IV; rae303
- *USD994, xdh-1(ok3234) IV; rae303, outcrossed one time
- *USD973, xdh-1(ok3234) IV; rae304
- CRISPR/Cas9-derived stains:
- USD1035, gda-1(rae335) III
- USD1036, gda-1(rae336) III
- *Whole genome sequencing data for these C. elegans strains have been deposited at the NIH Sequence Read Archive (SRA) under accession PRJNA1521815.
Chemical mutagenesis screen and whole genome sequencing
To identify genetic regulators of purine homeostasis, we performed a chemical mutagenesis screen to enhance the penetrance of xanthine stone formation in xdh-1(ok3234) mutant C. elegans (USD869). Animals were mutagenized using ethyl methanesulfonate (EMS) following established protocols [17,18]. Across multiple rounds of mutagenesis, we assessed roughly 100,000 mutagenized haploid genomes. Approximately 600 F2 animals displaying a xanthine stone were singled to establish independent lines, and their F3 progeny were further screened for increased penetrance of xanthine stone formation. Only viable, fertile mutants were retained for further analysis. The previously described sulp-4 alleles were recovered from the same screen [17].
We report the characterization of two new mutant strains, USD972 and USD973, each harboring EMS-induced lesions (rae303 and rae304, respectively) that enhanced xanthine stone formation in the xdh-1 mutant background. Both mutations were recessive. When heterozygous, rae303 and rae304 caused 0% (n = 32) and 1% (n = 95) xanthine stone formation in an xdh-1 mutant background respectively.
To determine whether these mutations affect the same gene, we performed complementation analysis in the xdh-1(ok3234) homozygous background. The rae303 lesion failed to complement rae304, with 93% xanthine stone penetrance observed in trans-heterozygotes (n = 40), indicating that both mutations disrupt the same genetic locus.
To identify the causative EMS-induced mutations, we performed whole-genome sequencing using established protocols [43]. Genomic DNA was extracted using the Gentra Puregene Tissue Kit (Qiagen), and libraries were prepared with the NEBNext DNA Library Prep Kit (New England Biolabs). Sequencing was conducted on an Illumina NovaSeq platform.
Reads were trimmed and aligned to the C. elegans reference genome (WBcel235) using standard workflows on the Galaxy platform [44–46]. Variant calling and annotation were performed to identify deviations from the reference genome and predict functional consequences [47–49].
Both USD972 and USD973 strains shared novel mutations in the gene Y48A6B.7, strongly implicating this locus in the enhanced xanthine stone phenotype observed in the USD972 and USD973 mutant strains (Fig 1B, 1C).
Quantifying xanthine and guanine stone penetrance
Xanthine and guanine stone formation was quantified using established methods with minor modifications [17]. Briefly, L4-stage animals were seeded onto NGM plates supplemented with 10 µM FUdR to prevent progeny hatching [50]. After 5 days, animals were assessed for the formation of an autofluorescent stone. All data points within each figure panel were collected under identical assay conditions and are directly comparable.
Xanthine stones were identified by the presence of highly autofluorescent puncta that appeared opaque under brightfield microscopy. Guanine stones were identified by the presence of weakly autofluorescent puncta that appeared opaque under brightfield microscopy. Stone penetrance was calculated as the percentage of animals that displayed at least one stone at the time of assessment. Missing or dead animals were excluded from the final analysis.
Quantifying C. elegans life history traits
Developmental rate, hatching efficiency, and brood size were quantified using synchronized populations of C. elegans. To determine developmental rate, gravid adult animals were treated with a bleach and sodium hydroxide solution to isolate embryos, which were incubated overnight in M9 buffer to induce hatching and arrest at the L1 stage [51]. These synchronized L1 larvae were cultured 72 hours at 20°C before imaging. Animal length was measured from head to tail using ImageJ software (NIH).
Hatching rate was assessed by collecting eggs from synchronized young adult animals and scoring the number of hatched larvae after approximately 24 hours.
To quantify brood size, individual L4 animals were cloned onto NGM seeded with E. coli. Individuals were transferred daily to new plates until the cessation of egg laying. Plates carrying progeny were incubated to allow eggs to hatch, and total brood size was determined by counting the number of hatched progeny. Animals that died or were lost during the assay were excluded from the final analysis.
CRISPR/Cas9 genome editing
Genome editing of the gda-1/Y48A6B.7 locus was performed using established CRISPR/Cas9 protocols [52,53]. Two guide RNAs (crRNAs; IDT) targeting gda-1 were designed with the sequences 5′-accccatcacgctgagcaca-3′ and 5′-tatccatgcccaatgtgcat-3′. Ribonucleoprotein complexes consisting of Cas9 protein (IDT) and guide RNAs were assembled and microinjected into the germline of C. elegans [53]. Progeny of injected animals were screened for deletions using PCR with the following primers: 5′-ccgtagtaaattgcgtcgaa-3′ and 5′-aaagctcgtcgctgataagg-3′. Two independent deletion alleles, gda-1(rae335) and gda-1(rae336), were isolated, made homozygous, and confirmed by Sanger sequencing.
Microscopy
Fluorescence and low-magnification brightfield images were acquired using a Nikon SMZ25 stereomicroscope equipped with a Hamamatsu ORCA-Flash 4.0 digital camera and NIS-Elements imaging software (Nikon). Fluorescent images of metabolic stones were visualized and imaged using the EGFP BP (FITC/Cy2) HC Filter Set (Nikon). High-magnification differential interference contrast (DIC) and GFP fluorescence images were captured as single optical planes using a Nikon NiE compound microscope, also equipped with a Hamamatsu ORCA-Flash 4.0 digital camera and NIS-Elements software.
All images were processed and analyzed using ImageJ software (NIH). Live C. elegans were immobilized using sodium azide prior to imaging. For metabolite imaging, xanthine and guanine (Millipore Sigma) were prepared on microscope slides, covered with coverslips, and sealed with nail polish.
GFP fluorescence was quantified by measuring the average pixel intensity across an entire animal using Image J software (NIH). Background fluorescence was determined from a defined region of interest that did not contain any C. elegans and was subtracted from the sample measurements. GFP intensity values were normalized to the wild-type control, which was set to 1.
Plasmid construction and transgenesis
Plasmid construction was performed using isothermal (Gibson) assembly [54]. For cloning C. elegans gda-1 and gda-2, the loci were amplified from the start codon to the stop codon, including all exons and introns, and assembled with an N-terminal green fluorescent protein (GFP). For cloning B. subtilis guanine deaminase, the coding sequence was amplified from start codon to stop codon and assembled with an N-terminal GFP. The gda-1 promoter was defined as the 985 bp upstream of the gda-1 start codon. The gda-2 promoter was defined as the 1,446 bp upstream of the gda-2 start codon. The sng-1 neural-specific promoter was defined as the 2,080 bp upstream of the sng-1 start codon. The col-10 hypodermal-specific promoter was defined as the 1,129 bp upstream of the col-10 start codon. The myo-3 muscle-specific promoter was defined as the 2,168 bp upstream of the myo-3 start codon. The sulp-4 excretory cell-specific promoter was defined as the 1,330 bp upstream of the sulp-4 start codon. The vha-6 intestine-specific promoter was defined as the 934 bp upstream of the vha-6 start codon. Site directed mutagenesis was performed on pSB3 and pSB7 to generate pSB9 and pSB10 respectively following manufacturer’s instructions (New England Biolabs). Plasmid sequences were verified by long-read sequencing using Plasmidsaurus, a commercial nanopore-based sequencing service. Plasmids generated for this work are listed below:
- pSB3, (Pgda-1::GFP::GDA-1)
- pSB9, (Pgda-1::GFP::GDA-1[H65A])
- pSB6, (Pgda-1::GFP::GDA-2)
- pSB7, (Pgda-1::GFP::BsGDA)
- pSB10, (Pgda-1::GFP::BsGDA[H53A])
- pSB13, (Pgda-2::GFP::GDA-2)
- pSB14, (Psng-1::GFP::GDA-2)
- pSB15, (Pcol-10::GFP::GDA-2)
- pSB16, (Pmyo-3::GFP::GDA-2)
- pSB17, (Pvha-6::GFP::GDA-2)
- pSB18, (Psulp-4::GFP::GDA-2)
Transgenic animals carrying extrachromosomal arrays were generated by injecting the gonad of young adult C. elegans with a plasmid of interest (2–20ng/µL), a Pmyo-2::mCherry co-injection marker (2ng/µL), and DNA scaffold (78–96 ng/µL KB+ ladder, New England Biolabs) [24,55].
mRNA isolation and quantification by qPCR
Wild-type and gda-1(rae336) synchronized young adult C. elegans were washed in M9 buffer prior to RNA extraction using TRIzol Reagent (Invitrogen), following the manufacturer’s instructions. Total RNA was reverse-transcribed into cDNA using the GoScript Reverse Transcriptase System (Promega).
Quantitative PCR (qPCR) was performed using the CFX96 Real-Time System (Bio-Rad) with SYBR Green Master Mix (Applied Biosystems), according to the manufacturer’s protocols. Relative mRNA levels were calculated using the comparative CT (ΔΔCT) method and normalized to the average expression of ama-1 mRNA [56]. qPCR primers were:
- ama-1, 5’-agtgccgagattgaaggaga-3’ and 5’-gtattgcatgttacctttttcaacg-3’
- gda-1, 5’-attcggtgcggttgtagtt-3’ and 5’-tgggcatggatagcaagatg-3’
- xdh-1: 5’-gggacgaatgtcggaagaatag-3’ and 5’-cgaatcgagttggtgtcaagta-3’
- gda-2: 5’-gatgggaaggtaatcggtagtg-3’ and 5’-catggatagcaggaagtgtagag-3’
- hprt-1: 5’-gtgtgctcgttgtggatgata-3’ and 5’-tccaatccgtagccaacaataa-3’
- pnp-1: 5’-ggatgcaacgatcccagatt-3’ and 5’-caccctcgtacaacgtcatatc-3’
- adah-1: 5’-tggtggtccaaaggaagttatt-3’ and 5’-atggaacagcaccagtcatt-3’
- cpin-1: 5’-catttggaagaacaacccaaaga-3’ and 5’-gctttgagaacaggagcatattg-3’
- gmps-1: 5’-tgtccagtttcatccagaagtag-3’ and 5’-gacacctccagacaccattac-3’
Metabolite quantification
Synchronized populations of approximately 5,000 young adult C. elegans were cultured under standard conditions. Animals were harvested and washed thoroughly in M9 buffer to remove residual dietary E. coli. All subsequent extraction steps took place at 4°C. Worm pellets were flash-frozen in liquid nitrogen and subsequently homogenized with 1.5mm high impact zirconium beads using a BeadBug homogenizer (Benchmark Scientific). C. elegans extracts were then centrifuged at 12,000 rpm for five minutes. The supernatant was then filtered through a 10 kDa molecular weight cutoff filter (Pierce), diluted 1:10 with water, and freeze-dried (Harvest Right) to produce the C. elegans metabolite extracts.
Metabolites were quantified using isotope dilution mass spectrometry. Freeze-dried C. elegans metabolite extracts were resuspended in 50 µL of H2O containing 0.0075% (v/v) formic acid and the appropriate isotope-labeled internal standards. Samples were vortexed for 20 seconds and incubated at 30°C with shaking at 1000 rpm for 30 minutes. After centrifugation at 50,000 x g for 30 minutes, the supernatant was transferred to mass spectrometry vials.
Quantification of nucleosides, nucleobases, uric acid, and allantoin was performed using an Agilent 1200 HPLC system coupled to an Agilent 6470C triple quadrupole mass spectrometer. Chromatographic separation was achieved using a Polaris 5 C18-A column (50 × 4.6 mm; Agilent Technologies) operated at 30°C with a flow rate of 0.650 mL/min. Mobile phase A consisted of: 75 µL/L formic acid in 100% H2O and mobile phase B consisted of 75 µL/L formic acid in 100% methanol (MeOH). The injection volume was 10 µL. Analyses were conducted in positive ion mode for nucleosides and nucleobases, and in negative ion mode for uric acid and allantoin, using multiple-reaction monitoring (MRM).
Evolutionary analyses of C. elegans guanine deaminases
To approximate the distribution of the two classes of guanine deaminases across the tree of life, we used B. subtilis GDA (WP_043857361) or E. coli GuaD (CAD6004693.1) as BLASTp queries. For each guanine deaminase query, a BLASTp search against the ClusteredNR database (NIH) of various animal phylum and superphylum was performed. For each BLASTp search, the top 50 bit scores were collected. When 50 significant bit scores were not returned, all significant bit scores were considered.
To evaluate potential horizontal gene transfer events, a local nematode database was built using 37 nematode genomes obtained from WormBase [57]. Using C. elegans proteins GDA-1 (NP_499418.1) and GDA-2 (NP_498663.1) as query, 52 nematode homologs were curated using BLASTp [58]. These nematode sequences were aligned using MAFFT v7.49 to generate an HMM profile with HMMER v3.3.2 (hmmbuild) [59,60]. To identify prokaryotic homologs, the same C. elegans query proteins were searched via BLASTp against a local GTDB-derived database containing prokaryotic genomes with >95% completeness and <5% contamination. The BLAST hits were further filtered using the nematode-based HMM profile (hmmsearch) to increase specificity [59]. The resulting prokaryotic sequences were clustered at 70% identity using CD-HIT [61], resulting a dataset of 722 prokaryotic proteins.
To obtain a species tree for gene/species tree reconciliation, the organisms in the protein dataset were searched against Open Tree of Life [62], identifying 237 matching taxa which were retrieved for species tree. GDA protein sequences (n = 257) that belong to 237 taxa were aligned using MAFFT v7.49 and a maximum-likelihood gene tree was constructed using IQTREE v2.0.3 by selecting LG + R10 as evolutionary model using ModelFinder [60,63,64]. Gene/species tree reconciliation was then performed using Amalgamated Likelihood Estimation (ALE) calculating the rates of horizontal gene transfer events [65].
Declaration of generative AI and AI-assisted technologies in the writing process
During the preparation of this work, the author(s) used Microsoft Copilot to improve the clarity and readability of the text. All content was reviewed and edited by the author(s), who take full responsibility for the final version of the manuscript.
Statistics
All statistical tests were performed using GraphPad Prism software.
Supporting information
S1 Fig. cdo-1 was not required for xanthine stone formation in gda-1; xdh-1 mutant animals.
Xanthine stone formation in various mutant C. elegans was assessed. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; t test.
https://doi.org/10.1371/journal.pgen.1012379.s001
(TIFF)
S2 Fig. Expression of various C. elegans transgenes.
Representative brightfield (left) and fluorescence (right) images of gda-1; xdh-1 double mutant C. elegans expressing A) Pgda-1::GFP::GDA-1, B) Pgda-1::GFP::GDA-1[H65A], C) Pgda-1::GFP::BsGDA, or D) Pgda-1::GFP::BsGDA[H53A] transgenes. Animals were imaged at the L4 stage of development. Note, fluorescence images in A-C are directly comparable (20ms exposure) while fluorescence image in D was taken at a higher 50ms exposure to visualize GFP. Scale bars: 100 μm.
https://doi.org/10.1371/journal.pgen.1012379.s002
(TIFF)
S4 Fig. gda-1 loss of function did not increase gda-2 mRNA or protein levels in C. elegans.
A) Total RNA was isolated from wild-type and gda-1(rae336) animals at the young adult stage. Transcript levels were quantified by qPCR and analyzed using the delta-delta CT method. All values were normalized to ama-1 expression, and relative abundance for each transcript was set to 1 in wild type. Individual data points represent biological replicates; mean and standard deviation are displayed. ns, not significant; *, p < 0.05; ****, p < 0.0001; t test. B) Quantification of GFP expression from two distinct extrachromosomal arrays carrying the Pgda-2::GFP::GDA-2 transgene. Wild-type and gda-1(rae336) animals expressing Pgda-2::GFP::GDA-2 were imaged at the L4 stage of development. Individual datapoints are biological replicates; mean and standard deviation are displayed. ns, not significant; t test. Complete details on sample size and individuals scored per biological replicate are provided in S1 Table. C) Representative fluorescence images of the Pgda-2::GFP::GDA-2 (raeEx150) transgene in wild-type and gda-1(rae336) mutant C. elegans at the L4 stage. Scale bars: 100 μm.
https://doi.org/10.1371/journal.pgen.1012379.s004
(TIFF)
S5 Fig. gda-1 promoted C. elegans fecundity.
A) Wild-type and gda-1(rae336) mutant C. elegans were synchronized at the L1 larval stage and cultured for 72 hours. Animal length was measured for each individual. Data are presented as individual points with mean and standard deviation. Sample size: 15 animals per genotype. *, p < 0.05; t test. B) The hatching rate of newly laid wild-type and gda-1(rae336) mutant C. elegans embryos was measured. Each data point represents a biological replicate. Mean and standard deviation are shown. ns, not significant; t test. C) Brood size of wild-type and mutant C. elegans was measured. Each data point represents a biological replicate. Mean and standard deviation are shown. **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ordinary one-way ANOVA, Dunnett’s multiple comparison test. Complete details on sample size and individuals scored per biological replicate are provided in S1 Table.
https://doi.org/10.1371/journal.pgen.1012379.s005
(TIFF)
S6 Fig. GDA-2 was expressed in multiple tissues.
A) Brightfield (top) and fluorescence (bottom) images of gda-2 gda-1 double mutant C. elegans expressing the Pgda-2::GFP::GDA-2 transgene. Animals were imaged at the L4 stage of development. Scale bar: 100 μm. B) Transgenic gda-1; xdh-1 animals expressing Pgda-1::GFP::GDA-2 or Pgda-2::GFP::GDA-2, along with their non-transgenic siblings, were scored for xanthine stone formation. Data points represent biological replicates. Mean and standard deviation are displayed. ns, not significant; **, p < 0.01; ****, p < 0.0001; t test. C) Guanine stone formation was assessed in transgenic gda-2 gda-1 C. elegans expressing GFP::GDA-2 driven by the native promoter (gda-2) and promoters specific to hypodermis (col-10), excretory cell (sulp-4), neurons (sng-1), muscle (myo-3), or intestine (vha-6). Three independent extrachromosomal arrays were assessed for each tissue of interest. Data points represent biological replicates. ns, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001; t test. Mean and standard deviation are displayed. Complete details on sample size and individuals scored per biological replicate are provided in S1 Table.
https://doi.org/10.1371/journal.pgen.1012379.s006
(TIFF)
S7 Fig. Expression of various C. elegans transgenes.
Representative brightfield (left) and fluorescence (right) images of gda-2 gda-1 double mutant C. elegans expressing GFP::GDA-2 transgene driven by the A) hypodermal col-10, B) excretory cell sulp-4, C) neuronal sng-1, D) muscle myo-3, or E) intestinal vha-6 promoters. Animals were imaged at the L4 stage of development. Scale bars: 100 μm.
https://doi.org/10.1371/journal.pgen.1012379.s007
(TIFF)
S8 Fig. Analysis of purine metabolites in wild-type and mutant C. elegans.
A) Heat map displaying the relative (log2 fold change) amounts of purine metabolites for wild-type and various mutant C. elegans. Values are normalized to the wild type. Each cell represents the average of three biological replicates. Raw data are provided in S1 Table. B) Quantification of purine metabolites from extracts of wild-type young adult C. elegans. Individual datapoints are biological replicates; mean and standard deviation are displayed.
https://doi.org/10.1371/journal.pgen.1012379.s008
(TIFF)
S9 Fig. Bright autofluorescent stones displayed by gda-2 gda-1; xdh-1 mutant C. elegans.
Brightfield (A,C) and fluorescence (B,D) images are displayed of the posterior of gda-1; xdh-1 (A,B) or gda-2 gda-1; xdh-1 (C,D) mutant C. elegans at day three of adulthood. Scale bars: 250 μm.
https://doi.org/10.1371/journal.pgen.1012379.s009
(TIFF)
Acknowledgments
Some C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC). gda-2(tm10990) was provided by the National Bio-Resource Project (NBRP). We would also like to thank the Center for High Throughput Computing (CHTC) at the University of Wisconsin-Madison for providing computing resources.
References
- 1.
Alsmark C, Foster PG, Sicheritz-Ponten T, Nakjang S, Martin Embley T, Hirt RP. Patterns of prokaryotic lateral gene transfers affecting parasitic microbial eukaryotes. Genome Biol. 2013;14(2):R19. pmid:23442822
- 2.
Eme L, Gentekaki E, Curtis B, Archibald JM, Roger AJ. Lateral Gene Transfer in the Adaptation of the Anaerobic Parasite Blastocystis to the Gut. Curr Biol. 2017;27(6):807–20. pmid:28262486
- 3.
von Wintersdorff CJH, Penders J, van Niekerk JM, Mills ND, Majumder S, van Alphen LB, et al. Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer. Front Microbiol. 2016;7:173. pmid:26925045
- 4.
Acuña R, Padilla BE, Flórez-Ramos CP, Rubio JD, Herrera JC, Benavides P, et al. Adaptive horizontal transfer of a bacterial gene to an invasive insect pest of coffee. Proc Natl Acad Sci U S A. 2012;109(11):4197–202. pmid:22371593
- 5.
Moran NA, Jarvik T. Lateral transfer of genes from fungi underlies carotenoid production in aphids. Science. 2010;328(5978):624–7. pmid:20431015
- 6.
Pandey T, Kalluraya CA, Wang B, Xu T, Huang X, Guang S, et al. Acquired stress resilience through bacteria-to-nematode interdomain horizontal gene transfer. EMBO J. 2023;42(24):e114835. pmid:37953666
- 7.
Wang B, Pandey T, Long Y, Delgado-Rodriguez SE, Daugherty MD, Ma DK. Co-opted genes of algal origin protect C. elegans against cyanogenic toxins. Curr Biol. 2022;32(22):4941–8.e3. pmid:36223775
- 8.
Danchin EGJ, Rosso M-N, Vieira P, de Almeida-Engler J, Coutinho PM, Henrissat B, et al. Multiple lateral gene transfers and duplications have promoted plant parasitism ability in nematodes. Proc Natl Acad Sci U S A. 2010;107(41):17651–6. pmid:20876108
- 9.
Han Z, Sieriebriennikov B, Susoy V, Lo W-S, Igreja C, Dong C, et al. Horizontally Acquired Cellulases Assist the Expansion of Dietary Range in Pristionchus Nematodes. Mol Biol Evol. 2022;39(2):msab370. pmid:34978575
- 10.
Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23(5):275–94. pmid:36973407
- 11.
Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med. 1964;36:561–70. pmid:14142409
- 12.
Duran M, Beemer FA, van de Heiden C, Korteland J, de Bree PK, Brink M, et al. Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport?. J Inherit Metab Dis. 1978;1(4):175–8. pmid:117254
- 13.
Sebesta I. Genetic disorders resulting in hyper- or hypouricemia. Adv Chronic Kidney Dis. 2012;19(6):398–403. pmid:23089275
- 14.
Ball EG. Xanthine oxidase: purification and properties. J Biol Chem. 1939;128(1):51–67.
- 15.
Dent CE, Philpot GR. Xanthinuria, an inborn error (or deviation) of metabolism. Lancet. 1954;266(6804):182–5. pmid:13118765
- 16.
Pais VM Jr, Lowe G, Lallas CD, Preminger GM, Assimos DG. Xanthine urolithiasis. Urology. 2006;67(5):1084.e9-11. pmid:16698380
- 17.
Snoozy J, Bhattacharya S, Johnson B, Fettig RR, Van Asma A, Brede C, et al. XDH-1 inactivation causes xanthine stone formation in Caenorhabditis elegans which is inhibited by SULP-4-mediated anion exchange in the excretory cell. PLoS Biol. 2025;23(9):e3003410. pmid:40991662
- 18.
Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. pmid:4366476
- 19.
Liaw S-H, Chang Y-J, Lai C-T, Chang H-C, Chang G-G. Crystal structure of Bacillus subtilis guanine deaminase: the first domain-swapped structure in the cytidine deaminase superfamily. J Biol Chem. 2004;279(34):35479–85. pmid:15180998
- 20.
Tecle E, Chhan CB, Franklin L, Underwood RS, Hanna-Rose W, Troemel ER. The purine nucleoside phosphorylase pnp-1 regulates epithelial cell resistance to infection in C. elegans. PLoS Pathog. 2021;17(4):e1009350. pmid:33878133
- 21.
Warnhoff K, Ruvkun G. Molybdenum cofactor transfer from bacteria to nematode mediates sulfite detoxification. Nat Chem Biol. 2019;15(5):480–8. pmid:30911177
- 22.
Blum M, Andreeva A, Florentino LC, Chuguransky SR, Grego T, Hobbs E, et al. InterPro: the protein sequence classification resource in 2025. Nucleic Acids Res. 2025;53(D1):D444–56. pmid:39565202
- 23.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10. pmid:2231712
- 24.
Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10(12):3959–70. pmid:1935914
- 25.
Nygaard P, Bested SM, Andersen KAK, Saxild HH. Bacillus subtilis guanine deaminase is encoded by the yknA gene and is induced during growth with purines as the nitrogen source. Microbiology (Reading). 2000;146 Pt 12:3061–9. pmid:11101664
- 26.
Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319(5):E827–34. pmid:32893671
- 27.
Fernández JR, Byrne B, Firestein BL. Phylogenetic analysis and molecular evolution of guanine deaminases: from guanine to dendrites. J Mol Evol. 2009;68(3):227–35. pmid:19221682
- 28.
Maynes JT, Yuan RG, Snyder FF. Identification, expression, and characterization of Escherichia coli guanine deaminase. J Bacteriol. 2000;182(16):4658–60. pmid:10913105
- 29.
Fernández JR, Welsh WJ, Firestein BL. Structural characterization of the zinc binding domain in cytosolic PSD-95 interactor (cypin): Role of zinc binding in guanine deamination and dendrite branching. Proteins. 2008;70(3):873–81. pmid:17803218
- 30.
Telford MJ, Budd GE, Philippe H. Phylogenomic Insights into Animal Evolution. Curr Biol. 2015;25(19):R876-87. pmid:26439351
- 31.
Yuan G, Bin JC, McKay DJ, Snyder FF. Cloning and characterization of human guanine deaminase. Purification and partial amino acid sequence of the mouse protein. J Biol Chem. 1999;274(12):8175–80. pmid:10075721
- 32.
Crisp A, Boschetti C, Perry M, Tunnacliffe A, Micklem G. Expression of multiple horizontally acquired genes is a hallmark of both vertebrate and invertebrate genomes. Genome Biol. 2015;16(1):50. pmid:25785303
- 33.
Salzberg SL. Horizontal gene transfer is not a hallmark of the human genome. Genome Biol. 2017;18(1):85. pmid:28482857
- 34.
Appleford PJ, Griffiths M, Yao SYM, Ng AML, Chomey EG, Isaac RE, et al. Functional redundancy of two nucleoside transporters of the ENT family (CeENT1, CeENT2) required for development of Caenorhabditis elegans. Mol Membr Biol. 2004;21(4):247–59. pmid:15371014
- 35.
Guan Y, Yu Y, Gao SM, Ding L, Zhao Q, Wang MC. Cross-tissue coordination between SLC nucleoside transporters regulates reproduction in Caenorhabditis elegans. PLoS Genet. 2025;21(5):e1011425. pmid:40446206
- 36.
Yanagi KS, Jochim B, Kunjo SO, Breen P, Ruvkun G, Lehrbach N. Mutations in nucleotide metabolism genes bypass proteasome defects in png-1/NGLY1-deficient Caenorhabditis elegans. PLoS Biol. 2024;22(7):e3002720. pmid:38991033
- 37.
Takagaki N, Ohta A, Ohnishi K, Kawanabe A, Minakuchi Y, Toyoda A, et al. The mechanoreceptor DEG-1 regulates cold tolerance in Caenorhabditis elegans. EMBO Rep. 2020;21(3):e48671. pmid:32009302
- 38.
Eyal Z, Deis R, Gorelick-Ashkenazi A, Barzilay Y, Broder Y, Kellum AP, et al. pH variations enable guanine crystal formation within iridosomes. Nat Chem Biol. 2026;22(1):19–27. pmid:40897845
- 39.
Gur D, Moore AS, Deis R, Pang S, Wu X, Pinkas I, et al. The physical and cellular mechanism of structural color change in zebrafish. Proc Natl Acad Sci U S A. 2024;121(23):e2308531121. pmid:38805288
- 40.
Mojzeš P, Gao L, Ismagulova T, Pilátová J, Moudříková Š, Gorelova O, et al. Guanine, a high-capacity and rapid-turnover nitrogen reserve in microalgal cells. Proc Natl Acad Sci U S A. 2020;117(51):32722–30. pmid:33293415
- 41.
Palmer BA, Taylor GJ, Brumfeld V, Gur D, Shemesh M, Elad N, et al. The image-forming mirror in the eye of the scallop. Science. 2017;358(6367):1172–5. pmid:29191905
- 42.
Hu PJ. Dauer. WormBook. 2007. p. 1–19.
- 43.
Lehrbach NJ, Ji F, Sadreyev R. Next-Generation Sequencing for Identification of EMS-Induced Mutations in Caenorhabditis elegans. Curr Protoc Mol Biol. 2017;117:7.29.1-7.29.12. pmid:28060408
- 44.
Galaxy Community. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 2022;50(W1):W345–51. pmid:35446428
- 45.
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20. pmid:24695404
- 46.
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589–95. pmid:20080505
- 47.
Wilm A, Aw PPK, Bertrand D, Yeo GHT, Ong SH, Wong CH, et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 2012;40(22):11189–201. pmid:23066108
- 48.
Cingolani P, Patel VM, Coon M, Nguyen T, Land SJ, Ruden DM, et al. Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift. Front Genet. 2012;3:35. pmid:22435069
- 49.
Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80–92. pmid:22728672
- 50.
Gandhi S, Santelli J, Mitchell DH, Stiles JW, Sanadi DR. A simple method for maintaining large, aging populations of Caenorhabditis elegans. Mech Ageing Dev. 1980;12(2):137–50. pmid:6445025
- 51.
Stiernagle T. Maintenance of C. elegans. WormBook. 2006;1–11. pmid:18050451
- 52.
Ghanta KS, Mello CC. Melting dsDNA Donor Molecules Greatly Improves Precision Genome Editing in Caenorhabditis elegans. Genetics. 2020;216(3):643–50. pmid:32963112
- 53.
Cho SW, Lee J, Carroll D, Kim J-S, Lee J. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics. 2013;195(3):1177–80. pmid:23979576
- 54.
Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–5. pmid:19363495
- 55.
Frøkjaer-Jensen C, Davis MW, Hopkins CE, Newman BJ, Thummel JM, Olesen S-P, et al. Single-copy insertion of transgenes in Caenorhabditis elegans. Nat Genet. 2008;40(11):1375–83. pmid:18953339
- 56.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8. pmid:18546601
- 57.
Sternberg PW, Van Auken K, Wang Q, Wright A, Yook K, Zarowiecki M, et al. WormBase 2024: status and transitioning to Alliance infrastructure. Genetics. 2024;227(1). pmid:38573366
- 58.
Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421. pmid:20003500
- 59.
Eddy SR. Accelerated Profile HMM Searches. PLoS Comput Biol. 2011;7(10):e1002195. pmid:22039361
- 60.
Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–80. pmid:23329690
- 61.
Fu L, Niu B, Zhu Z, Wu S, Li W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012;28(23):3150–2. pmid:23060610
- 62.
McTavish EJ, Hinchliff CE, Allman JF, Brown JW, Cranston KA, Holder MT, et al. Phylesystem: a git-based data store for community-curated phylogenetic estimates. Bioinformatics. 2015;31(17):2794–800. pmid:25940563
- 63.
Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol Biol Evol. 2020;37(5):1530–4. pmid:32011700
- 64.
Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587–9. pmid:28481363
- 65.
Szöllõsi GJ, Rosikiewicz W, Boussau B, Tannier E, Daubin V. Efficient exploration of the space of reconciled gene trees. Syst Biol. 2013;62(6):901–12. pmid:23925510